The firm now intends to set up an internal laboratory to experiment with different compounds, while building out its team.
The collaboration will place T1D in the field of precision medicine, potentially allowing JDRF to identify factors that potentially lead to T1D.
Researchers developed a gene expression-based classifier for four gastric cancer subtypes and found that some are associated with better outcomes than others.
The Brown University spinout wants to apply its algorithms to help improve personalized cancer treatments.
Precision medicine platform developer 2bPrecise, a subsidiary of Allscripts, will develop and test genomics care protocols with Mayo Clinic.
The researchers used SC3 to uncover subclones within samples from patients with pre-malignant tumors.
The Croatan algorithm uses the random forest machine learning method to evaluate guide RNAs for use in CRISPR knockout experiments.
Researchers used the approach, which analyzes somatic copy number alterations, to identify a targetable pathway, which they then blocked effectively using currently available drugs.
In PNAS this week: DNA regulation in islet cells, algorithm predicts regulatory element marks in various tissues, and more.
The algorithm identifies proteins in blood samples taken after bone marrow transplants that predict patients at risk for severe graft-versus-host disease.
A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.
Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.
Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.
In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.